Taipei Exchange - Delayed Quote TWD

Genomics BioSci & Tech. Co.,Ltd. (4195.TWO)

Compare
18.90
+0.40
+(2.16%)
At close: 1:56:37 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
396,142.00
396,142.00
419,003.00
389,965.00
443,176.00
Cost of Revenue
276,232.00
276,232.00
282,994.00
280,042.00
288,163.00
Gross Profit
119,910.00
119,910.00
136,009.00
109,923.00
155,013.00
Operating Expense
204,904.00
204,904.00
167,669.00
139,156.00
144,359.00
Operating Income
-84,994.00
-84,994.00
-31,660.00
-29,233.00
10,654.00
Net Non Operating Interest Income Expense
-2,693.00
-2,693.00
-1,631.00
-1,405.00
175.00
Pretax Income
-167,941.00
-167,941.00
72,260.00
12,092.00
-3,103.00
Tax Provision
125.00
125.00
664.00
--
-1,652.00
Net Income Common Stockholders
-168,066.00
-168,066.00
71,596.00
18,738.00
619.00
Diluted NI Available to Com Stockholders
-168,066.00
-168,066.00
71,596.00
18,738.00
619.00
Basic EPS
-2.36
--
1.13
0.31
0.01
Diluted EPS
-2.36
--
1.13
0.31
0.01
Basic Average Shares
71,107.00
--
63,329.00
60,713.14
61,053.13
Diluted Average Shares
71,107.00
--
63,562.00
60,867.16
61,149.10
Total Expenses
481,136.00
481,136.00
450,663.00
419,198.00
432,522.00
Net Income from Continuing & Discontinued Operation
-168,066.00
-168,066.00
71,596.00
18,738.00
619.00
Normalized Income
-170,540.40
-170,540.40
73,435.94
18,164.00
3,865.40
Interest Income
2,093.00
2,093.00
353.00
265.00
1,173.00
Interest Expense
4,786.00
4,786.00
1,984.00
1,670.00
998.00
Net Interest Income
-2,693.00
-2,693.00
-1,631.00
-1,405.00
175.00
EBIT
-163,155.00
-163,155.00
74,244.00
13,762.00
-2,105.00
EBITDA
-123,177.00
-123,177.00
107,216.00
47,719.00
33,099.00
Reconciled Cost of Revenue
276,232.00
276,232.00
282,994.00
280,042.00
288,163.00
Reconciled Depreciation
39,978.00
39,978.00
32,972.00
33,957.00
35,204.00
Net Income from Continuing Operation Net Minority Interest
-168,066.00
-168,066.00
71,596.00
18,738.00
619.00
Total Unusual Items Excluding Goodwill
3,093.00
3,093.00
-1,857.00
574.00
-4,058.00
Total Unusual Items
3,093.00
3,093.00
-1,857.00
574.00
-4,058.00
Normalized EBITDA
-126,270.00
-126,270.00
109,073.00
47,145.00
37,157.00
Tax Rate for Calcs
0.00
0.00
0.00
--
0.00
Tax Effect of Unusual Items
618.60
618.60
-17.06
--
-811.60
12/31/2020 - 12/16/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

6610.TWO TWi Biotechnology, Inc.
13.75
+0.73%
 
6652.TWO Eusol Biotech Co.,Ltd.
7.51
-3.72%
 
4194.TWO Holy Stone Healthcare Co., Ltd.
11.40
-0.44%
 
4197.TWO Visgeneer Inc.
9.78
0.00%
 
7754.TWO AnnJi
32.85
-2.81%
 
6564.TWO Enimmune corporation
26.80
-0.56%
 
6814.TWO Lukas Biomedical Inc.
27.60
0.00%
 
7814.TWO HORIEN
33.25
-4.04%
 
4186.TWO Taiwan Advance Bio-Pharmaceutical Inc.
16.05
+0.94%
 
4170.TWO VBI
13.75
-1.79%